DIALYSIS · CCN 212593

DaVita Silver Spring Dialysis

SILVER SPRING, MD 20910

DialysisProfitDaVita
$6.4M
TOTAL REVENUE
33.8%
OPERATING MARGIN
3 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.4M
Total costs
$4.2M
Operating income (rev − costs)
$2.2M
Operating margin
33.8%
Total charges
$6.4M
Total treatments
13,728
Dialysis stations
27

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.7876—
Fistula Rate
DFC_FISTULA_RATE
63.6111—
Five Star Rating
DFC_FIVE_STAR
3——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.9132—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
5——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
13285—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0.3——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
14111—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
21.6332—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
19.497—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
32.447—
Standardized ED Visits Ratio
DFC_SEDR
0.9150—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
26.645—